Differences in release mechanisms and distributions for sialyl Lea and sialyl Le(x) antigens in colorectal cancer

Annals of Surgical Oncology

Volumn 7, Issue 4, 2000, Pages 289-295

  Nakagoe, Tohru ^a,b   Sawai, Terumitsu ^a   Tsuji, Takashi ^a   Jibiki, Masaaki ^a   Ohbatake, Masayuki ^a   Nanashima, Atsushi ^a   Yamaguchi, Hiroyuki ^a   Yasutake, Toru ^a   Ayabe, Hiroyoshi ^a   Tagawa, Yutaka ^b  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; Drainage vein; Sialyl Le(x); Sialyl Lea

Indexed keywords

CARBOHYDRATE ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP LEWIS SYSTEM; CANCER INVASION; CANCER STAGING; COLORECTAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PERIPHERAL VEIN; PORTAL VEIN; TUMOR VOLUME;

EID: 18344405597     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-000-0289-1     Document Type: Article

References (28)

1. Dabelsteen E. Cell surface carbohydrates as prognostic markers in human carcinomas. J Pathol 1996;179:358-69.
2. Hakomori S. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res 1985;45:2405-14.
3. Arends JW, Verstynen C, Bosman FT, Hilgers JO, Steplewski Z. Distribution of monoclonal antibody-defined monosialoganglioside in normal and cancerous human tissues: an immunoperoxidase study. Hybridoma 1983;2:219-29.
4. Fukushi Y, Kannagi R, Hakomori S, Shepard T, Kulander BG, Singer JW. Location and distribution of difucoganglioside (VI3NcuAcV3III3Fuc2nLc6) in normal and tumor tissues defined by its monoclonal antibody FH6. Cancer Res 1985;45:3711-7.
5. x antigens in primary colorectal carcinomas and lymph node and hepatic lesions. J Gastroenterol 1994;29:129-38.
6. Fukushima K, Hirota M, Terasaki PI, et al. Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res 1984;44:5279-85.
7. a as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer 1995;75: 2051-6.
8. x antigen in relation to survival of patients with colorectal carcinoma. Cancer 1993;72:2323-30.
9. Nakagoe T, Kusano H, Hirota M, et al. Serological and immunohistochemical studies on sialylated carbohydrate antigens in colorectal carcinoma. Gastroenterol Jpn 1991;26:303-11.
10. Filella X, Molina R, Grau JJ, et al. Prognostic value of CA19.9 levels in colorectal cancer. Ann Surg 1992;216:55-9.
11. Ueda T, Shimada E, Urakawa T. The clinicopathological features of serum CA19-9-positive colorectal cancers. Surg Today 1994; 24:518-25.
12. a for serological tests of cancer. Cancer Res 1985;45:435-7.
13. Imura H, Endo J, Ohkura H, et al. Initial basic and clinical evaluation of a solid-phase immunoradiometric assay for sialyl SSEA-1 antigen: 2. Evaluation of clinical significance. Jpn J Cancer Chemother 1987;14:1322-31.
14. Tabuchi Y, Deguchi H, Imanishi K, Saitoh Y. Comparison of carcinoembryonic antigen levels between portal and peripheral blood in patients with colorectal cancer: correlation with histopathologic variables. Cancer 1987;59:1283-8.
15. Tabuchi Y, Deguchi H, Saitoh Y. Carcinoembryonic antigen and carbohydrate antigen 19-9 levels of peripheral and draining venous blood in colorectal cancer patients: correlation with histopathologic and immunohistochemical variables. Cancer 1988; 62:1605-13.
16. Zamcheck N. Doos WG, Prudente R, Lurie BB, Gottlieb LS. Prognostic factors in colon carcinoma: correlation of serum carcinoembryonic antigen level and tumor histopathology. Hum Pathol 1975;6:31-45.
17. Sugarbaker PH. Carcinoembryonic antigen (CEA) assays in obstructive colorectal cancer. Ann Surg 1976;184:752-7.
18. Hamada Y, Yamamura M, Hioki K, Yamamoto M, Nagura H, Watanabe K. Immunohistochemical study of carcinoembryonic antigen in patients with colorectal cancer: correlation with plasma carcinoembryonic antigen levels. Cancer 1985;55:136-41.
19. Wagener C, Muller-Wallraf R, Nisson S, Groner J, Breuer H. Localization and concentration of carcinoembryonic antigen (CEA) in gastrointestinal tumors: correlation with CEA levels in plasma. J Natl Cancer Inst 1981;67:539-47.
20. Martin KW, Halpern SE. Carcinoembryonic antigen production, secretion, and kinetics in BALB/c mice and a nude mouse-human tumor model. Cancer Res 1984;44:5475-81.
21. AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven, 1997.
22. Jass JR, Sobin LH. World Health Organization International Histological Classification of Tumours: Histological Typing of Intestinal Tumours. 2nd ed. New York: Springer-Verlag, 1989.
23. Del Villano BC, Brennan S, Brock P, et al. Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA19-9. Clin Chem 1983;29:549-52.
24. Imura H, Endo J, Ohkura H, et al. Initial basic and clinical evaluation of a solid-phase immunoradiometric assay for sialyl SSEA-1 antigen: 1. Evaluation of assay conditions and normal values. Jpn J Cancer Chemother 1987;14:1315-21.
25. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, John Wiley & Sons, 1990.
26. Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival in cirrhotics. Hepatology 1987;7:660-4.
27. Kannagi R, Kitahara A, Itai S, et al. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing epitopes consisting of sialyl or sialyl-fucosyl type 1 chain. Cancer Res 1988;48:3856-63.
28. Kannagi R, Fukushi Y, Tachikawa T, et al. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine. Cancer Res 1986;46:2619-26.